This IS the Biggest News in Breast Cancer Management in 2016!!!
From now on, if a woman is being offered chemotherapy for early breast cancer, she needs to check to see if she is eligible to have MammaPrint genomic testing - which has now shown a 46% reduction in the need for chemotherapy in those women who return a low risk MammaPrint test!
As of today, the world of breast cancer management has changed forever, with the prospectively randomised proven introduction of MammaPrint testing!
Read full details here: http://www.mammaprint.com.au/targeted-breast-cancer-medical-treatment-now-a-reality-mindact-is-out/
No comments:
Post a Comment